Education
About Us
Working with TipRanks
Follow Us
Bo Kruse Insider Profile
4 Followers
Bo Kruse, EVP, CFO, SECRY & TREAS at Y-Mabs Therapeutics, holds 210.88K shares in Y-Mabs Therapeutics (Ticker: YMAB).
Bo Kruse Y-Mabs Therapeutics (YMAB)EVP, CFO, SECRY & TREAS
Y-Mabs Therapeutics (YMAB)
EVP, CFO, SECRY & TREAS
Ranked #36,688 out of 106,131 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+36.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Bo Kruse does not currently own shares as a corporate insider.
A breakdown of Bo Kruse's holdings
Insider Roles
Bo Kruse does not currently hold a role as a corporate insider.
Roles that Bo Kruse holds in companies
Most Profitable Insider Trade
Stock:
Y-Mabs Therapeutics
(YMAB)
(YMAB)
Rating:Informative Sell
Date:May 31, 2024 - May 31, 2025
Return:+61.90%
The most profitable trade made by Bo Kruse
Bo Kruse's Trading History
List of latest transactions for each holding click on a transaction to see Bo Kruse's performance on stock
You May Also Like
Bo Kruse insider profile FAQ
What is the percentage of profitable transactions made by Bo Kruse?
The percentage of profitable transactions made by Bo Kruse is 100%.
What is the average return per transaction made by Bo Kruse?
The average return per transaction made by Bo Kruse is 36.60%.
What stocks does Bo Kruse hold?
Bo Kruse holds: YMAB stocks.
What was Bo Kruse’s latest transaction?
Bo Kruse latest transaction was an Uninformative Buy of $120.00K.
What was Bo Kruse's most profitable transaction?
Bo Kruse’s most profitable transaction was an Informative Sell of YMAB stock on May 31, 2024. The return on the trade was 61.90%.
What is Bo Kruse's role in Y-Mabs Therapeutics?
Bo Kruse's role in Y-Mabs Therapeutics is EVP, CFO, SECRY & TREAS.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.